13F-HR filed by Healthcare Value Capital, LLC
Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 19 holding rows worth $53,307,000.
- Accession
- 0000919574-19-005281
- Filer
- CIK 1458461
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 19 entries on the cover page, a total value of $53,307,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $53,307,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 150,000 | $10,134,000 | thousands by filing date | call |
| SPY | 78462F103 | SHS | 20,000 | $5,860,000 | thousands by filing date | put |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 120,000 | $4,802,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 70,000 | $4,729,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 50,000 | $3,636,000 | thousands by filing date | call |
| Johnson & Johnson | 478160104 | COM | 25,000 | $3,482,000 | thousands by filing date | call |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 25,000 | $2,854,000 | thousands by filing date | put |
| CVS Health Corporation | 126650100 | COM | 50,000 | $2,725,000 | thousands by filing date | call |
| TYME TECHNOLOGIES INC COM | 90238J103 | Stock | 2,175,000 | $2,654,000 | thousands by filing date | |
| GREENLANE HLDGS INC | 395330103 | CL A | 250,000 | $2,398,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 50,000 | $2,166,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 250,000 | $2,075,000 | thousands by filing date | |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 1,800,000 | $1,404,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 200,000 | $1,240,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 6,000 | $1,034,000 | thousands by filing date | put |
| CRONOS GROUP INC | 22717L101 | COM | 50,000 | $799,000 | thousands by filing date | put |
| ANTARES PHARMA INC | 036642106 | COM | 200,000 | $658,000 | thousands by filing date | call |
| Proshares VIX Short-Term | 74347W171 | Equity | 25,000 | $535,000 | thousands by filing date | call |
| TYME TECHNOLOGIES INC COM | 90238J103 | Stock | 100,000 | $122,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-19-005281 | this filing | 2019-08-14 | acceptance time not in the bulk data set |